A revolutionary new treatment for rheumatoid arthritis. #StartActivating #SetPointSystem #SetPointTherapy Individual outcomes vary. Safety info: spm.care/ISI
Valencia, CA
Based in United States
- Tweets 151
- Following 43
- Followers 614
- Likes 35
See important safety information at spm.care/ISI.
33
Thank you, @CCRheumatology for a great weekend. Seeing #NeuroimmuneModulation presented as an RA treatment — and met with real enthusiasm — says a lot about where this field is headed. Learn more: healio.com/news/rheumatology…
#StartActivating #SetPointAdvantage #Rheumatology
1
101
The first patient in the Pacific Northwest has been treated with the #SetPointSystem for rheumatoid arthritis at @OHSUNews, bringing #SetPointTherapy to communities across Oregon.
Read more: setpointmedical.com/setpoint…
Individual outcomes vary. See ISI: spm.care/ISI
2
5
308
Join us and @USSONAR_Rh Monday, October 5th at 8:30 pm ET for a webinar with Dr. Jeffrey Curtis (UAB) to discuss vagus nerve-mediated neuroimmune modulation, a novel therapy treatment for rheumatoid arthritis.
Register today: spm.care/webinar
4
167
(1/2) New on @HRheuminations: @LCalabreseDO and Dr. Chernoff explore the story behind vagus nerve’s anti-inflammatory pathways, the science of neuroimmune modulation, & the clinical journey leading to its use in rheumatoid arthritis.
Listen: spm.care/healio_107
#RA
🚨Special episode alert 🚨Rheuminations guest host @LCalabreseDO speaks with David Chernoff, MD @SetPointMed about vagal nerve stimulation and recent developments in immune mediated disease. Listen here 🎙️vist.ly/5cwhx
#Rheumatology #Podcast
1
3
4
685
Shared decision-making is a core @ACRheum recommendation for RA management — meaning treatment decisions should reflect what matters most to each patient.
New peer-reviewed research explores exactly that. 🧵
1
3
3
154
Excited to see @SetPointMed co-founder @KevinJTraceyMD recognized for his outstanding work pioneering the science of neuroimmune modulation. An excellent addition to the @AcadofInventors 2025 Class of Fellows! @NorthwellHealth businesswire.com/news/home/2…
1
4
275
We’re honored that the SetPoint System has been named one of @TIME’s Best Inventions of 2025 in Medical & Healthcare. 🏆
Read about it here: time.com/collections/best-in…
Please see important safety information at spm.care/ISI
#TIMEBestInventions #StartActivating #RA
2
8
2,847
Big news today! @NorthwellHealth is the first health system in the nation to provide the recent FDA-approved #SetPointSystem, implanting its first patient on Aug. 22. Read about it: setpointmedical.com/northwel… #SetPointTherapy #RheumatoidArthritis #RheumTwitter #NeuroimmuneModulation
3
13
678
We're so pleased to see this coverage of the FDA approval of the #SetPointSystem in the @nytimes! Read the full story to learn more about the life-changing power of neuroimmune modulation:
nytimes.com/2025/07/31/healt…
Safety info in bio.
#Rheumatology #RheumTwitter #MedTwitter
2
17
2,302
It’s official! #SetPointSystem is now FDA approved for the treatment of rheumatoid arthritis (RA) in adults who are not adequately managed by, or who cannot tolerate, existing advanced RA therapies.
See the release: setpointmedical.com/setpoint… #Rheumatology #RheumTwitter #MedTwitter
4
5
19
8,321
We were honored to have our national surgical PI @RMarkRichardson present RESET-RA results during the Plenary Session at #AANS25.
Data presented highlight SetPoint System’s potential as a first-of-its-kind neuroimmune modulation treatment for RA.
#TheSetPointAdvantage
1
4
336
Nice story by @NPR about how neuroimmune modulation is unlocking new possibilities for treating autoimmune diseases like #RA.
npr.org/sections/shots-healt…
#TheSetPointAdvantage
The SetPoint System is limited by U.S. law to investigational use only.
2
12
401
We're thrilled to announce positive topline results from our RESET-RA clinical study for rheumatoid arthritis (#RA)!
The Setpoint System is limited by United States law to investigational use only.
Read the full announcement:
setpointmedical.com/setpoint…
#TheSetPointAdvantage
1
8
1,804
We're happy to share that, following the recent Breakthrough Device Designation, Setpoint's neuroimmune modulation platform for the treatment of MS has now been accepted into the FDA's TAP Pilot!
#TheSetPointAdvantage
Learn more in our press release: setpointmedical.com/setpoint…
3
12
648
🎉 Big news incoming:
SetPoint’s novel neuroimmune modulation platform received Breakthrough Device Designation from the FDA for multiple sclerosis (MS) treatment!
Learn more here:
#MSAwarenessWeek #TheSetPointAdvantage
setpointmedical.com/setpoint…
1
7
296
SetPoint Medical’s co-founder @KevinJTraceyMD spoke with @katiecouric about the innovative field of neuroimmune modulation and our ongoing RESET-RA trial investigating this novel treatment option for RA patients.
Check it out: katiecouric.com/health/vagus…
1
5
307
We're working to prove the value of neuroimmune modulation in #rheumatology, aiming to bring new options for patients.
"This is the brand-new field of neuromodulation for the treatment of autoimmune disease,” explains our CMO.
Check out the latest buzz: the-rheumatologist.org/artic…
2
346
Big day for @SetPointMed! Just announced: $145M in new financing to support the development of our therapeutic platform; includes $80M in equity financing co-led by @NorwestVP & Viking Global Investors, as well as $65M credit facility with @RunwayGrowth. bwnews.pr/3CZGlJL
1
2
7
1,115
Read more about our groundbreaking research for autoimmune diseases like rheumatoid arthritis in this recent article in @IEEESpectrum. #TheSetPointAdvantage #Immunology #Rheumatology #Autoimmune spectrum.ieee.org/amp/rhumat…
2
141